GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:2000351
|
BP
|
regulation of endothelial cell apoptotic process
|
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
|
TEK
|
GO:2000352
|
BP
|
negative regulation of endothelial cell apoptotic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
|
KRIT1,
FGA,
FGB,
FGG,
SERPINE1,
ICAM1,
SCG2,
TNFAIP3,
TEK,
MAPK7,
SEMA5A,
GAS6,
ANGPT1,
NDNF
|
GO:2000353
|
BP
|
positive regulation of endothelial cell apoptotic process
|
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
FOXO3,
THBS1,
CD40LG,
COL18A1,
PRKCI,
AKR1C3,
ANO6,
GPER1,
RGCC,
CD248
|
GO:2000354
|
BP
|
regulation of ovarian follicle development
|
Any process that modulates the frequency, rate or extent of ovarian follicle development.
|
GNRH1
|
GO:2000355
|
BP
|
negative regulation of ovarian follicle development
|
Any process that stops, prevents or reduces the frequency, rate or extent of ovarian follicle development.
|
AMH
|
GO:2000360
|
BP
|
negative regulation of binding of sperm to zona pellucida
|
Any process that stops, prevents or reduces the frequency, rate or extent of binding of sperm to the zona pellucida.
|
ZP3
|
GO:2000366
|
BP
|
positive regulation of STAT protein import into nucleus
|
Any process that activates or increases the frequency, rate or extent of STAT protein import into nucleus.
|
IL6,
LEP,
ERBB4
|
GO:2000368
|
BP
|
positive regulation of acrosomal vesicle exocytosis
|
Any process that activates or increases the frequency, rate or extent of acrosomal vesicle exocytosis.
|
ZP3
|
GO:2000369
|
BP
|
regulation of clathrin-dependent endocytosis
|
Any process that modulates the frequency, rate or extent of clathrin-mediated endocytosis.
|
PIK3CB,
TNK2,
AAK1
|
GO:2000370
|
BP
|
positive regulation of clathrin-dependent endocytosis
|
Any process that activates or increases the frequency, rate or extent of clathrin-mediated endocytosis.
|
WASL,
DAB2
|
GO:2000373
|
BP
|
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity
|
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
|
PLSCR1,
HNRNPU,
UHRF1
|
GO:2000376
|
BP
|
positive regulation of oxygen metabolic process
|
Any process that activates or increases the frequency, rate or extent of oxygen metabolic process.
|
MT3
|
GO:2000377
|
BP
|
regulation of reactive oxygen species metabolic process
|
Any process that modulates the frequency, rate or extent of reactive oxygen species metabolic process.
|
PARK2,
TUSC2,
ARF4,
MPV17,
EIF6,
FOXM1,
FOXO1,
CYP1B1,
PID1,
PINK1
|
GO:2000378
|
BP
|
negative regulation of reactive oxygen species metabolic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species metabolic process.
|
PARK2,
CRYAB,
MYCN,
BCL2,
G6PD,
MT3,
BRCA1,
PLIN5,
BNIP3,
HIF1A,
SIRT2,
PINK1,
AATF
|
GO:2000379
|
BP
|
positive regulation of reactive oxygen species metabolic process
|
Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
|
F2,
AGT,
PDGFB,
TP53,
THBS1,
PDGFRB,
NQO2,
CD36,
GADD45A,
TSPO,
AGTR1,
TGFBR2,
CDKN1A,
LEP,
AKR1C3,
XDH,
ROMO1,
GRB2,
RIPK1,
MAPK14,
DUOXA1,
PID1,
NOX4
|
GO:2000386
|
BP
|
positive regulation of ovarian follicle development
|
Any process that activates or increases the frequency, rate or extent of ovarian follicle development.
|
ZP3
|
GO:2000388
|
BP
|
positive regulation of antral ovarian follicle growth
|
Any process that activates or increases the frequency, rate or extent of antral ovarian follicle growth.
|
ZP3
|
GO:2000391
|
BP
|
positive regulation of neutrophil extravasation
|
Any process that activates or increases the frequency, rate or extent of neutrophil extravasation.
|
IL1A,
IL1R1,
ADAM8
|
GO:2000393
|
BP
|
negative regulation of lamellipodium morphogenesis
|
Any process that stops, prevents or reduces the frequency, rate or extent of lamellipodium morphogenesis.
|
KANK1,
ARPIN
|
GO:2000394
|
BP
|
positive regulation of lamellipodium morphogenesis
|
Any process that activates or increases the frequency, rate or extent of lamellipodium morphogenesis.
|
ENPP2,
ARHGEF7,
CORO1B,
CORO1C
|
GO:2000402
|
BP
|
negative regulation of lymphocyte migration
|
Any process that stops, prevents or reduces the frequency, rate or extent of lymphocyte migration.
|
WASL
|
GO:2000405
|
BP
|
negative regulation of T cell migration
|
Any process that stops, prevents or reduces the frequency, rate or extent of T cell migration.
|
APOD
|
GO:2000406
|
BP
|
positive regulation of T cell migration
|
Any process that activates or increases the frequency, rate or extent of T cell migration.
|
CCL5,
CXCL12,
CCL20,
PYCARD
|
GO:2000415
|
BP
|
positive regulation of fibronectin-dependent thymocyte migration
|
Any process that activates or increases the frequency, rate or extent of fibronectin-dependent thymocyte migration.
|
ADAM8
|
GO:2000418
|
BP
|
positive regulation of eosinophil migration
|
Any process that activates or increases the frequency, rate or extent of eosinophil migration.
|
ADAM8
|
GO:2000420
|
BP
|
negative regulation of eosinophil extravasation
|
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil extravasation.
|
PTGER4
|
GO:2000425
|
BP
|
regulation of apoptotic cell clearance
|
Any process that modulates the frequency, rate or extent of apoptotic cell clearance.
|
ITGAV
|
GO:2000427
|
BP
|
positive regulation of apoptotic cell clearance
|
Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
|
C3,
C4A,
C4B,
CCL2,
MFGE8
|
GO:2000438
|
BP
|
negative regulation of monocyte extravasation
|
Any process that stops, prevents or reduces the frequency, rate or extent of monocyte extravasation.
|
PLCB1
|
GO:2000439
|
BP
|
positive regulation of monocyte extravasation
|
Any process that activates or increases the frequency, rate or extent of monocyte extravasation.
|
PDGFD
|
GO:2000446
|
BP
|
regulation of macrophage migration inhibitory factor signaling pathway
|
Any process that modulates the frequency, rate or extent of macrophage migration inhibitory factor signaling pathway.
|
ANGPT1
|
GO:2000454
|
BP
|
positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation
|
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta cytotoxic T cell extravasation.
|
FADD
|
GO:2000458
|
BP
|
regulation of astrocyte chemotaxis
|
Any process that modulates the frequency, rate or extent of astrocyte chemotaxis.
|
GPR183
|
GO:2000463
|
BP
|
positive regulation of excitatory postsynaptic potential
|
Any process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
|
PTEN,
DLG4,
NLGN1,
NRXN1,
RIMS2
|
GO:2000465
|
BP
|
regulation of glycogen (starch) synthase activity
|
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
|
PPP1R3F
|
GO:2000466
|
BP
|
negative regulation of glycogen (starch) synthase activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
|
GSK3B,
INPP5K
|
GO:2000467
|
BP
|
positive regulation of glycogen (starch) synthase activity
|
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
|
IGF2,
ADIPOQ,
EPM2AIP1
|
GO:2000473
|
BP
|
positive regulation of hematopoietic stem cell migration
|
Any process that activates or increases the frequency, rate or extent of hematopoietic stem cell migration.
|
PTPRC
|
GO:2000478
|
BP
|
positive regulation of metanephric glomerular visceral epithelial cell development
|
Any process that activates or increases the frequency, rate or extent of metanephric glomerular visceral epithelial cell development.
|
ADIPOQ
|
GO:2000479
|
BP
|
regulation of cAMP-dependent protein kinase activity
|
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
|
MST1,
SESN2
|
GO:2000480
|
BP
|
negative regulation of cAMP-dependent protein kinase activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
|
PRKAR1A,
PRKAR2A,
PRKAR2B,
PKIA,
PKIG
|
GO:2000481
|
BP
|
positive regulation of cAMP-dependent protein kinase activity
|
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
|
ATP2B4,
ADIPOQ
|
GO:2000482
|
BP
|
regulation of interleukin-8 secretion
|
Any process that modulates the frequency, rate or extent of interleukin-8 secretion.
|
CRP
|
GO:2000483
|
BP
|
negative regulation of interleukin-8 secretion
|
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-8 secretion.
|
ANXA1,
ANXA4,
PTPN22
|
GO:2000484
|
BP
|
positive regulation of interleukin-8 secretion
|
Any process that activates or increases the frequency, rate or extent of interleukin-8 secretion.
|
CD58,
F2R,
WNT5A,
F2RL1,
HYAL2,
CD244,
PYCARD
|
GO:2000486
|
BP
|
negative regulation of glutamine transport
|
Any process that stops, prevents or reduces the frequency, rate or extent of glutamine transport.
|
LEP
|
GO:2000490
|
BP
|
negative regulation of hepatic stellate cell activation
|
Any process that stops, prevents or reduces the frequency, rate or extent of hepatic stellate cell activation.
|
GCLC,
CYGB
|
GO:2000491
|
BP
|
positive regulation of hepatic stellate cell activation
|
Any process that activates or increases the frequency, rate or extent of hepatic stellate cell activation.
|
PDGFRB,
LEP,
RPS6KA1
|
GO:2000502
|
BP
|
negative regulation of natural killer cell chemotaxis
|
Any process that stops, prevents or reduces the frequency, rate or extent of natural killer cell chemotaxis.
|
CCL2
|
GO:2000503
|
BP
|
positive regulation of natural killer cell chemotaxis
|
Any process that activates or increases the frequency, rate or extent of natural killer cell chemotaxis.
|
CXCL14,
CCL3,
CCL4,
CCL5
|
GO:2000504
|
BP
|
positive regulation of blood vessel remodeling
|
Any process that activates or increases the frequency, rate or extent of blood vessel remodeling.
|
TMBIM1
|
GO:2000505
|
BP
|
regulation of energy homeostasis
|
Any process that modulates the frequency, rate or extent of energy homeostasis.
|
CD36,
LEPR,
PRKAA2,
FOXO1,
NR1D2,
BMP8A,
NR4A3,
PASK
|
GO:2000506
|
BP
|
negative regulation of energy homeostasis
|
Any process that stops, prevents or reduces the frequency, rate or extent of energy homeostasis.
|
FLCN,
GHRL
|
GO:2000507
|
BP
|
positive regulation of energy homeostasis
|
Any process that activates or increases the frequency, rate or extent of energy homeostasis.
|
TRPV4,
PPARGC1A,
GHRL
|
GO:2000510
|
BP
|
positive regulation of dendritic cell chemotaxis
|
Any process that activates or increases the frequency, rate or extent of dendritic cell chemotaxis.
|
CALR,
IL12A,
C1QBP,
GAS6
|
GO:2000516
|
BP
|
positive regulation of CD4-positive, alpha-beta T cell activation
|
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
|
CD55
|
GO:2000521
|
BP
|
negative regulation of immunological synapse formation
|
Any process that stops, prevents or reduces the frequency, rate or extent of immunological synapse formation.
|
LGALS3
|
GO:2000533
|
BP
|
negative regulation of renal albumin absorption
|
Any process that stops, prevents or reduces the frequency, rate or extent of renal albumin absorption.
|
GAS6
|
GO:2000534
|
BP
|
positive regulation of renal albumin absorption
|
Any process that activates or increases the frequency, rate or extent of renal albumin absorption.
|
ADIPOQ
|
GO:2000535
|
BP
|
regulation of entry of bacterium into host cell
|
Any process that modulates the frequency, rate or extent of entry of bacterium into host cell.
|
CXCL8,
CAV1,
EXOC2,
FUCA2,
EXOC7
|
GO:2000536
|
BP
|
negative regulation of entry of bacterium into host cell
|
Any process that stops, prevents or reduces the frequency, rate or extent of entry of bacterium into host cell.
|
ITGAV
|
GO:2000541
|
BP
|
positive regulation of protein geranylgeranylation
|
Any process that activates or increases the frequency, rate or extent of protein geranylgeranylation.
|
MUSK
|
GO:2000543
|
BP
|
positive regulation of gastrulation
|
Any process that activates or increases the frequency, rate or extent of gastrulation.
|
OTX2,
RACK1,
TENM4,
OSR1
|
GO:2000544
|
BP
|
regulation of endothelial cell chemotaxis to fibroblast growth factor
|
Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
|
FGF2
|
GO:2000546
|
BP
|
positive regulation of endothelial cell chemotaxis to fibroblast growth factor
|
Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
|
FGF18,
FGF2,
FGFR1
|
GO:2000553
|
BP
|
positive regulation of T-helper 2 cell cytokine production
|
Any process that activates or increases the frequency, rate or extent of T-helper 2 cell cytokine production.
|
IL6
|
GO:2000560
|
BP
|
positive regulation of CD24 biosynthetic process
|
Any process that activates or increases the frequency, rate or extent of CD24 biosynthetic process.
|
PLCB1
|
GO:2000563
|
BP
|
positive regulation of CD4-positive, alpha-beta T cell proliferation
|
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation.
|
CD55
|
GO:2000564
|
BP
|
regulation of CD8-positive, alpha-beta T cell proliferation
|
Any process that modulates the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
|
IRF1
|
GO:2000566
|
BP
|
positive regulation of CD8-positive, alpha-beta T cell proliferation
|
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
|
HLA-E,
CD244
|
GO:2000568
|
BP
|
positive regulation of memory T cell activation
|
Any process that activates or increases the frequency, rate or extent of memory T cell activation.
|
TNFSF4
|
GO:2000570
|
BP
|
positive regulation of T-helper 2 cell activation
|
Any process that activates or increases the frequency, rate or extent of T-helper 2 cell activation.
|
TNFSF4,
PRKCQ
|
GO:2000572
|
BP
|
positive regulation of interleukin-4-dependent isotype switching to IgE isotypes
|
Any process that activates or increases the frequency, rate or extent of interleukin-4-dependent isotype switching to IgE isotypes.
|
TNFSF4
|
GO:2000573
|
BP
|
positive regulation of DNA biosynthetic process
|
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
|
PAK3,
MYC,
PDGFB,
PDGFRB,
HGF,
PRKD2,
RGCC,
NOX4
|
GO:2000574
|
BP
|
regulation of microtubule motor activity
|
Any process that modulates the frequency, rate or extent of microtubule motor activity.
|
CCDC42B,
NDEL1,
NDE1
|
GO:2000584
|
BP
|
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway
|
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
|
ADIPOQ
|
GO:2000587
|
BP
|
negative regulation of platelet-derived growth factor receptor-beta signaling pathway
|
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
|
PTPN2
|
GO:2000590
|
BP
|
negative regulation of metanephric mesenchymal cell migration
|
Any process that stops, prevents or reduces the frequency, rate or extent of metanephric mesenchymal cell migration.
|
ADIPOQ
|
GO:2000591
|
BP
|
positive regulation of metanephric mesenchymal cell migration
|
Any process that activates or increases the frequency, rate or extent of metanephric mesenchymal cell migration.
|
PDGFB
|
GO:2000594
|
BP
|
positive regulation of metanephric DCT cell differentiation
|
Any process that activates or increases the frequency, rate or extent of metanephric DCT cell differentiation.
|
PAX8
|
GO:2000601
|
BP
|
positive regulation of Arp2/3 complex-mediated actin nucleation
|
Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation.
|
WASL,
CYFIP1,
ABI2
|
GO:2000609
|
BP
|
regulation of thyroid hormone generation
|
Any process that modulates the frequency, rate or extent of thyroid hormone generation.
|
DUOXA1,
DUOXA2
|
GO:2000611
|
BP
|
positive regulation of thyroid hormone generation
|
Any process that activates or increases the frequency, rate or extent of thyroid hormone generation.
|
PAX8
|
GO:2000612
|
BP
|
regulation of thyroid-stimulating hormone secretion
|
Any process that modulates the frequency, rate or extent of thyroid-stimulating hormone secretion.
|
PAX8
|
GO:2000615
|
BP
|
regulation of histone H3-K9 acetylation
|
Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation.
|
CHEK1
|
GO:2000616
|
BP
|
negative regulation of histone H3-K9 acetylation
|
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 acetylation.
|
ZNF451
|
GO:2000617
|
BP
|
positive regulation of histone H3-K9 acetylation
|
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
|
BRCA1,
SMAD4,
NAP1L2
|
GO:2000620
|
BP
|
positive regulation of histone H4-K16 acetylation
|
Any process that activates or increases the frequency, rate or extent of histone H4-K16 acetylation.
|
BRCA1
|
GO:2000623
|
BP
|
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
|
Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
|
SECISBP2
|
GO:2000627
|
BP
|
positive regulation of miRNA catabolic process
|
Any process that activates or increases the frequency, rate or extent of miRNA catabolic process.
|
PNPT1
|
GO:2000628
|
BP
|
regulation of miRNA metabolic process
|
Any process that modulates the frequency, rate or extent of miRNA metabolic process.
|
KHSRP
|
GO:2000630
|
BP
|
positive regulation of miRNA metabolic process
|
Any process that activates or increases the frequency, rate or extent of miRNA metabolic process.
|
NFKB1,
RELA
|
GO:2000632
|
BP
|
negative regulation of pre-miRNA processing
|
Any process that stops, prevents or reduces the frequency, rate or extent of pre-microRNA processing.
|
BCDIN3D
|
GO:2000637
|
BP
|
positive regulation of gene silencing by miRNA
|
Any process that activates or increases the frequency, rate or extent of gene silencing by miRNA.
|
ZFP36,
STAT3,
FXR1,
FMR1,
PUM1,
PUM2,
AJUBA,
LIMD1
|
GO:2000641
|
BP
|
regulation of early endosome to late endosome transport
|
Any process that modulates the frequency, rate or extent of early endosome to late endosome transport.
|
MAPK3,
MAPK1,
MAP2K2,
MAP2K1
|
GO:2000642
|
BP
|
negative regulation of early endosome to late endosome transport
|
Any process that stops, prevents or reduces the frequency, rate or extent of early endosome to late endosome transport.
|
SNX3,
SNX12
|
GO:2000643
|
BP
|
positive regulation of early endosome to late endosome transport
|
Any process that activates or increases the frequency, rate or extent of early endosome to late endosome transport.
|
EZR,
RDX,
DAB2,
MTMR2,
RAB21
|
GO:2000645
|
BP
|
negative regulation of receptor catabolic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of receptor catabolic process.
|
MTMR2
|
GO:2000647
|
BP
|
negative regulation of stem cell proliferation
|
Any process that stops, prevents or reduces the frequency, rate or extent of stem cell proliferation.
|
SNAI2,
FBLN1
|
GO:2000648
|
BP
|
positive regulation of stem cell proliferation
|
Any process that activates or increases the frequency, rate or extent of stem cell proliferation.
|
KDM1A,
PTPRC,
EPCAM,
HMGA2
|